Additional information

Laboratory

Exult Diagnostics, Dr. Lal PathLabs, Oncquest Labs

Reviews

There are no reviews yet.

Be the first to review “CANCER TARGETED GENE PANEL : LUNG WITH PDL-1 (DAKO)”

Your email address will not be published. Required fields are marked *

CANCER TARGETED GENE PANEL : LUNG WITH PDL-1 (DAKO)

 27500 41000

EX0286      CANCER TARGETED GENE PANEL : LUNG WITH PDL-1 (DAKO)
Specimen: Submit formalin-fixed paraffin-embedded Tissue Block. Ship at room temperature. Tissue block must contain at least 10% tumor tissue. Provide a copy of the Histopathology report, Site of biopsy, and Clinical history.
Stability:
Room Refrigerated Frozen
NA NA NA
Method: IHC, FISH, NGS
Comment: Use test code J113 for Photomicrograph. Samples received on holidays will be reported in the next schedule / next working day.
Report: Contact us to know the TAT.
Usage: This panel aids in prognostication and therapeutic decisions for Lung carcinoma where a mutation has been demonstrated in MET, BRAF, EGFR, ERBB2, and KRAS and copy number variations in ALK1, ROS1, and MET. PD-L1 22C3 assay is indicated as a Companion Diagnostic aid in identifying patients for the treatment with KEYTRUDA (Pembrolizumab) therapy. It also enables the screening of clinically actionable targets for personalized targeted medicine in Lung adenocarcinoma.
Doctor Specialty: Oncologist
Disease: Cancer
Components: *ALK1 *ROS1 *MET amplification *MET mutation *KRAS *BRAF *ERBB2 *EGFR *PDL-1 (Dako)
Courier Charges:
Home Collection: Available (*T&C Apply)
Department: MOLECULAR DIAGNOSTICS
Pre Test Information: Provide a copy of the Histopathology report, Site of biopsy, and Clinical history. A duly filled NGS Test Requisition Form is mandatory.